MedPath

Effect of Amiodarone for preventing atrial fibrillation in cardiac surgery.

Not Applicable
Conditions
Health Condition 1: I20-I25- Ischemic heart diseasesHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2021/01/030750
Lead Sponsor
KIMSDU Karad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age from 18-60 years, Patients of both sex will be included.

2.Patient electively posted for CABG.

Exclusion Criteria

1.Allergic reaction to antiarrhythmic drugs.

2.Emergencies operations.

3.Pregnancy.

4.Redo surgery.

5.Patient Refusal.

6.Hypothyroid patients.

7.Patients who have preoperative arrhythmias.

8.Patients requiring more than 4 coronary artery bypass grafts.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amiodarone helps to prevent atrial fibrillation in cardiac surgical patietnts as compared to placebo represented by p value of less than 0.05Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Cost of therapy <br/ ><br>Prevention of other complications <br/ ><br>Hemodynamic ChangesTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath